Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.
More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback